Endpoints News

Endpoints News

Flagship startup loses chief exec to Ipsen		Read in browser

Thank you for reading, dupa dupackia!

basic

UPGRADE

M T W Th Fri

13 March, 2026

Is your biologics discovery built to maximize the impact of AI?

sponsored by Cradle

presented by

Southern Star Research

Southern Star Research expands Asia footprint through strategic investment in Expecto Health Science

spotlight

Who’s leading LGBTQ+ inclusion in biopharma? Nominate them for Endpoints’ annual report

news

Grail names new CEO as Bob Ragusa retires

Peer Review

Flagship startup loses CEO to Ipsen; Ionis to shed nearly six decades of board experience

In Focus

A simpler, single-strand form of DNA may be key to non-viral gene therapy, study suggests

In Focus

How GLP-1 weight loss compounders reshaped the drug industry

In Focus

After touching the $1T club, Eli Lilly CEO David Ricks is making the moves to stay there

Mar 24

11:30 am ET

From structure to selectivity: Federated AI for collaborative binding affinity prediction

sponsored by Rhino Federated Computing

US biopharma still leads the world in high-risk drug development, but the road from innovation to access has never been harder to predict. Hear from top executives and investors on how they’re navigating what’s next. Join us.

in case you missed it

1.

Biotechs find quick 'oxygen' using funding extensions to gain cash instead of full rounds

2.

Pfizer to close Ignite, its R&D services unit for small biotechs

3.

Lilly warns of impurity risk in certain compounded forms of Mounjaro and Zepbound

4.

Novo Holdings’ assets fell by a third in 2025 as Novo Nordisk’s value sank

5.

How bioRxiv changed the way biologists share ideas – in numbers

6.

China Approves First Brain Implant for Commercial Use

Reynald Castaneda

.

Over the past few days, our reporters took a deep dive into several key stories — non-viral gene therapies, GLP-1 compounders, and Lilly's next steps — perfect for your weekend read. See you on Monday!

.

Reynald Castaneda

Deputy Editor, Endpoints News

2029 Becker Drive; Lawrence, Kansas 66047 USA Privacy and deletion: help@endpointsnews.com

web